Aakaar Medical Technologies Makes Market Debut at ₹75, Lists at 4.17% Premium

June 27, 2025: Aakaar Medical Technologies Ltd IPO listed on the NSE SME platform, Emerge, on June 27, 2025, with an IPO of an entirely fresh issue of 37.5 lakh shares. With the demand from Qualified Institutional Buyers, Retail Investors and Non-Institutional Investors, the issue was oversubscribed by 2.28 times (overall).

Post-IPO, the promoters continue to hold a significant majority stake, with no shares pledged or encumbered, while the remaining portion is held by public shareholders, including institutional investors, alternative investment funds, and individual stakeholders.

The stock opened at ₹75, marking a premium from its issue price (₹72). The stock slipped later in the early session, trading at ₹71.60 as of 10:38 AM, hovering close to its current intraday low.

Listing Highlights

• Listing Price: ₹75
• Issue Price: ₹72
• Premium on Listing: ₹3 (4.17%)
• Day’s High/Low (as of 9:56 AM): ₹75 / ₹75
• Volume Traded: 2.96 lakh shares
• Total Traded Value: ₹2.22 crore
• Market Cap: ₹106.30 crore
• Face Value: ₹10
• Lot Size: 1,600 shares
• Trading Status: Active
• ISIN: INEGYP01013

The stock witnessed balanced demand in early trade, with a buy and sell quantity of 4,800 shares each at the time of observation.

IPO Recap and Investor Interest

Aakaar Medical Technologies’ ₹27 crore IPO closed on June 24 with an overall subscription of 2.28 times, driven by strong demand from Qualified Institutional Buyers (QIBs), who subscribed 3.51x, followed by Retail Investors (1.93x) and Non-Institutional Investors (1.48x).

The offering was entirely a fresh issue of 37.5 lakh shares, with proceeds intended for business expansion and general corporate purposes.

Promoter Holding and Share Structure

Post-IPO, promoters retain a 67.01% stake, with no pledged or encumbered shares, while the remaining 32.99% is held by public shareholders, including institutions, AIFs, and individuals.

Outlook

The oversubscription and modest listing premium suggest healthy investor interest and confidence in Aakaar Medical Technologies’ growth story. The near-term movement will depend on sustained trading volume, broader market sentiment, and how effectively the company deploys IPO proceeds for expansion.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations